These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28637559)

  • 21. Hernia Recurrence and Complications After Abdominal Reconstruction With Reinforced Versus Nonreinforced Biologic Mesh.
    Sweitzer K; O'Shea A; Tawil C; Weissberg J; Tomtschik J; Butterfield J; Fowler C; Langstein H; Bell D
    Ann Plast Surg; 2024 Apr; 92(4S Suppl 2):S196-S199. PubMed ID: 38556672
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Partial versus complete removal of the infected mesh after abdominal wall hernia repair.
    Bueno-Lledó J; Torregrosa-Gallud A; Carreño-Saénz O; García-Pastor P; Carbonell-Tatay F; Bonafé-Diana S; Iserte-Hernández J
    Am J Surg; 2017 Jul; 214(1):47-52. PubMed ID: 27939024
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biologic mesh for repair of ventral hernias in contaminated fields: long-term clinical and patient-reported outcomes.
    Madani A; Niculiseanu P; Marini W; Kaneva PA; Mappin-Kasirer B; Vassiliou MC; Khwaja K; Fata P; Fried GM; Feldman LS
    Surg Endosc; 2017 Feb; 31(2):861-871. PubMed ID: 27334966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resorbable Synthetic Meshes for Abdominal Wall Defects in Preclinical Setting: A Literature Review.
    Miserez M; Jairam AP; Boersema GSA; Bayon Y; Jeekel J; Lange JF
    J Surg Res; 2019 May; 237():67-75. PubMed ID: 30710881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The safety and efficacy of prosthetic hernia repair in clean-contaminated and contaminated wounds.
    Kelly ME; Behrman SW
    Am Surg; 2002 Jun; 68(6):524-8; discussion 528-9. PubMed ID: 12079133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of ventral hernia defect during enterocutaneous fistula takedown: practice patterns and short-term outcomes from the Abdominal Core Health Quality Collaborative.
    Fafaj A; Tastaldi L; Alkhatib H; Zolin SJ; Rosenblatt S; Huang LC; Phillips S; Krpata DM; Prabhu AS; Petro CC; Rosen MJ
    Hernia; 2021 Aug; 25(4):1013-1020. PubMed ID: 33389276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Open retromuscular mesh repair of complex incisional hernia: predictors of wound events and recurrence.
    Cobb WS; Warren JA; Ewing JA; Burnikel A; Merchant M; Carbonell AM
    J Am Coll Surg; 2015 Apr; 220(4):606-13. PubMed ID: 25797746
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Practice patterns in complex ventral hernia repair and place of biological grafts: a national survey among French digestive academic surgeons.
    Mariette C; Wind P; Micelli Lupinacci R; Tresallet C; Adham M; Arvieux C; Benoist S; Berdah S; Berger A; Briez N; Brigand C; Caiazzo R; Carrere N; Casa C; Collet D; Deguelte S; Dousset B; Dubuisson V; Glehen O; Gineste JC; Hamy A; Lacaine F; Laurent C; Lehur PA; Mabrut JY; Mathieu P; Mathonnet M; Meunier B; Michot F; Ouaissi M; Palot JP; Parc Y; Pattou F; Paye F; Pezet D; Piessen G; Pocard M; Regenet N; Regimbeau JM; Sabbagh C; Zerbib P; Toussaint JM
    J Visc Surg; 2014 Feb; 151(1):9-16. PubMed ID: 24388391
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preventing Recurrence in Clean and Contaminated Hernias Using Biologic Versus Synthetic Mesh in Ventral Hernia Repair: The PRICE Randomized Clinical Trial.
    Harris HW; Primus F; Young C; Carter JT; Lin M; Mukhtar RA; Yeh B; Allen IE; Freise C; Kim E; Sbitany H; Young DM; Hansen S
    Ann Surg; 2021 Apr; 273(4):648-655. PubMed ID: 33443907
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Observational Cohort Study on the Use of a Slowly Fully Resorbable Synthetic Mesh (Phasix™) in the Treatment of Complex Abdominal Wall Pathology with Different Grades of Contamination.
    van Driel LJ; Miserez M; Aarts F; Tollens T
    Surg Technol Int; 2021 May; 38():186-192. PubMed ID: 33823056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No enterocutaneous fistula development in a cohort of 695 patients after incisional hernia repair using intraperitoneal uncoated polyproylene mesh.
    Brandi CD; Roche S; Bertone S; Fratantoni ME
    Hernia; 2017 Feb; 21(1):101-106. PubMed ID: 27522361
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk factors, outcomes, and complications associated with combined ventral hernia and enterocutaneous fistula single-staged abdominal wall reconstruction.
    Klifto KM; Othman S; Messa CA; Piwnica-Worms W; Fischer JP; Kovach SJ
    Hernia; 2021 Dec; 25(6):1537-1548. PubMed ID: 33538927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biologic mesh is non-inferior to synthetic mesh in CDC class 1 & 2 open abdominal wall reconstruction.
    Shao JM; Ayuso SA; Deerenberg EB; Elhage SA; Prasad T; Colavita PD; Augenstein VA; Heniford BT
    Am J Surg; 2022 Feb; 223(2):375-379. PubMed ID: 34140156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Not all biologics are equal!
    Shah BC; Tiwari MM; Goede MR; Eichler MJ; Hollins RR; McBride CL; Thompson JS; Oleynikov D
    Hernia; 2011 Apr; 15(2):165-71. PubMed ID: 21188442
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of components separation for contaminated complex abdominal wall defects.
    Yegiyants S; Tam M; Lee DJ; Abbas MA
    Hernia; 2012 Feb; 16(1):41-5. PubMed ID: 21786148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Repair of recurrent hernia after biologic mesh failure in abdominal wall reconstruction.
    Purnell CA; Souza JM; Park E; Dumanian GA
    Am J Surg; 2014 Nov; 208(5):788-793. PubMed ID: 25118163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biologic versus synthetic mesh in open ventral hernia repair: A systematic review and meta-analysis of randomized controlled trials.
    Mazzola Poli de Figueiredo S; Tastaldi L; Mao RD; Lima DL; Huang LC; Lu R
    Surgery; 2023 Apr; 173(4):1001-1007. PubMed ID: 36623959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of abdominal wall reconstruction with acellular dermal matrix are not affected by wound contamination.
    Garvey PB; Martinez RA; Baumann DP; Liu J; Butler CE
    J Am Coll Surg; 2014 Nov; 219(5):853-64. PubMed ID: 25440025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects: a prospective study.
    Zerbib P; Caiazzo R; Piessen G; Rogosnitzky M; Séquier C; Koriche D; Truant S; Boleslawski E; Chambon JP; Pruvot FR
    Hernia; 2015 Apr; 19(2):253-7. PubMed ID: 24048636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective review and observations over a 16-year clinical experience on the surgical treatment of chronic mesh infection. What about replacing a synthetic mesh on the infected surgical field?
    Birolini C; de Miranda JS; Utiyama EM; Rasslan S
    Hernia; 2015 Apr; 19(2):239-46. PubMed ID: 24509890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.